SuperDendrix also identifies increased dependencies on PIK3CA and BCL2 in some of the same cancer types, including PIK3CA in myeloma and rhabdomyosarcoma and BCL2 in leukemia and myeloma.100. Here, PIK3CA is linked to cancer.